Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device could help dialysis patients track fluid removal

NCT ID NCT07217470

Summary

This small pilot study tested whether a new device called HemoCept could accurately measure fluid removal during dialysis treatments. Researchers enrolled 26 adults with end-stage kidney disease who had been on dialysis for at least 90 days. The study compared the device's readings with standard measurements of fluid weight changes to see if the technology works reliably.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESRD (END STAGE RENAL DISEASE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Sierra Nevad Specialty Care

    Reno, Nevada, 89511, United States

Conditions

Explore the condition pages connected to this study.